Evidence map›Paper›PMID 30815899›Full record

ArticleAmerican journal of hematology2019

Host genetic variation in tumor necrosis factor and nuclear factor-κB pathways and overall survival in mantle cell lymphoma: A discovery and replication study.

Yucai Wang, Thomas M Habermann, Sophia S Wang, Matthew J Maurer, Vivekananda Sarangi, Brian K Link, Andrew L Feldman, David J Inwards, Thomas E Witzig, Wendy Cozen and 4 more

Open access · bronzeAbstract readLetter
PubMed Full text at PMC Publisher
In one paragraph

Article in American journal of hematology, 2019. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 1 paper.

0numbers the graph read from it
0cells of the map it votes in
1citing papers in PubMed
0.2field-weighted citation impact, top 51% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

1 citing paper in PubMed, 2 citations in OpenAlex.

  1. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

14 authors at 7 institutions in 1 country.

Yucai WangDivision of Hematology, Mayo Clinic, Rochester, Minnesota.
Thomas M HabermannDivision of Hematology, Mayo Clinic, Rochester, Minnesota.
Sophia S WangDivision of Cancer Etiology, Department of Population Sciences, Beckman Research Institute, City of Hope National Medical Center, Duarte, California.
Matthew J MaurerDepartment of Health Sciences Research, Mayo Clinic, Rochester, Minnesota.
Vivekananda SarangiDepartment of Health Sciences Research, Mayo Clinic, Rochester, Minnesota.
Brian K LinkDivision of Hematology, Oncology, and Bone and Marrow Transplantation, University of Iowa, Iowa City, Iowa.
Andrew L FeldmanDepartment of Laboratory Medicine and Pathology, Mayo Clinic, Rochester, Minnesota.
David J InwardsDivision of Hematology, Mayo Clinic, Rochester, Minnesota.
Thomas E WitzigDivision of Hematology, Mayo Clinic, Rochester, Minnesota.ORCID 0000-0002-4215-6500
Wendy CozenDepartments of Preventive Medicine and Pathology, Keck School of Medicine of USC, University of Southern California, Los Angeles, California.
Nathaniel RothmanOccupational and Environmental Epidemiology Branch, Division of Cancer Epidemiology and Genetics, National Cancer Institute, Rockville, Maryland.
Yan AsmannDepartment of Health Sciences Research, Mayo Clinic, Jacksonville, Florida.
Susan L SlagerDepartment of Health Sciences Research, Mayo Clinic, Rochester, Minnesota.
James R CerhanDepartment of Health Sciences Research, Mayo Clinic, Rochester, Minnesota.ORCID 0000-0002-7482-178X
Mayo Clinic · USMayo Clinic in Florida · USCity Of Hope National Medical Center · USJacksonville College · USNational Cancer Institute · USUniversity of Iowa · USUniversity of Southern California · US

Funding

Viral VectorP30CA086862 · NCI · UNIVERSITY OF IOWA · PI Mark E Burkard · 2000 to 2026
$70.0M
The Role of Monocytes in non-Hodgkin LymphomaP50CA097274 · NCI · UNIVERSITY OF IOWA · PI HOUTMAN, JON C.D. · 2002 to 2021
$45.7M
The Lymphoma Epidemiology of Outcomes (LEO) Cohort Study (Supplement)U01CA195568 · NCI · MAYO CLINIC ROCHESTER · PI CERHAN, JAMES R, FLOWERS, CHRISTOPHER R · 2015 to 2025
$22.1M
SURVEILLANCE, EPIDEMIOLOGY, AND END RESULTS--SEERN01PC065064 · PC · WAYNE STATE UNIVERSITY · PI WEISS, LINDA K · 1996 to 2000
$4.5M
SURVEILLANCE EPIDEMIOLOGY &END RESULTS PROGRAMN01PC067008 · PC · UNIVERSITY OF IOWA · PI LYNCH, CHARLES · 1996 to 2000
$3.8M
SURVEILLANCE EPIDEMIOLOGY &END RESULTS PROGRAMN01PC067009 · PC · FRED HUTCHINSON CANCER RESEARCH CENTER · PI THOMAS, DAVID B · 1996 to 2000
$3.0M
Molecular Epidemiology of non-Hodgkin Lymphoma SurvivalR01CA129539 · NCI · MAYO CLINIC ROCHESTER · PI CERHAN, JAMES R · 2009 to 2010
$1.2M
Immunogenetics of Non-Hodgkin Lymphoma SurvivalR01CA096704 · NCI · MAYO CLINIC ROCHESTER · PI CERHAN, JAMES R · 2002 to 2006
$1.1M
Lymphoma Research FoundationNCI NIH HHS N01 PC035139NCI NIH HHS N01 PC065064NCI NIH HHS N01 PC067008NCI NIH HHS N01 PC067009NCI NIH HHS P50 CA097274NCI NIH HHS P50 CA97274NCI NIH HHS R01 CA096704NCI NIH HHS R01 CA129539NCI NIH HHS R01 CA96704NCI NIH HHS U01 CA195568SEER Contracts N01-PC65064SEER Contracts N01-PC71105
6 · The paper itself

Abstract

PubMed holds no abstract for this paper.

Indexed as

Lymphoma, Mantle-CellPolymorphism, Single NucleotideAdultDisease-Free SurvivalFemaleHumansMaleNeoplasm ProteinsNF-kappa BPilot ProjectsSurvival RateTumor Necrosis Factor-alphaNeoplasm ProteinsNF-kappa BTumor Necrosis Factor-alpha

Identifiers

PMID30815899
PMCPMC7085408
OpenAlexW2918678178

What OpenQuestion holds

Textmetadata
LicenceTDM
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.